AT-9283

AT-9283 is a potent AuroraA, AuroraB, JAK3, JAK2 enzyme inhibitor in addition to being an Abl family & Bcr-Abl inhibitor. As a potent inhibitor of these kinases this small molecule has proven to inhibit growth and survival of cancer cells in vivo.

References
[1] Curry, J., et. al.: Cell Cycle, 8, 1921 (2009).

[2] Santo L, et al. Antimyeloma activity of a multitargeted kinase inhibitor, AT9283, via potent Aurora kinase and STAT3 inhibition either alone or in combination with lenalidomide. Clin Cancer Res. 2011 May 15; 17(10):3259-71.

[3] Howard S, et al. Fragment-Based Discovery of the Pyrazol-4-yl Urea (AT9283), a Multitargeted Kinase Inhibitor with Potent Aurora Kinase Activity. Journal of Medicinal Chemistry (2009), 52(2), 379-388.

[4] Kimura S. AT-9283, a small-molecule multi-targeted kinase inhibitor for the potential treatment of cancer. Current Opinion in Investigational Drugs (London, England : 2000). 2010 Dec; 11(12):1442-1449.